Library

Protocol

GHRP-2 (10mg Vial)

Complete dosage protocol and reconstitution guide for GHRP-2 (10mg Vial).

Updated November 26, 2025 Research guide Research information only
Open calculator preset Build protocol outline TNHL options
Educational reference only. TNHL calculates and organizes user-entered values; it does not diagnose, prescribe, recommend doses, or replace guidance from a qualified professional.
MechanismGHRP-2 (pralmorelin) is a synthetic hexapeptide that potently stimulates growth hormone release by activating ghrelin receptors in the pituitary and hypothalamus [1] [2] . It has been used in clinical research as a diagnostic GH stimulant and in investigative treatment protocols for growth hormone deficiency [3] .
Dosing100–300 mcg once daily (gradual titration).
ReconstitutionAdd 3.0 mL diluent to a 10 mg vial.
StorageLyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; avoid freeze–thaw cycles.

Calculator preset

Run the vial math before tracking.

At ~3.33 mg/mL, 1 unit ~ 33.3 mcg ; 100 mcg ~ 3 units and 300 mcg ~ 9 units on a U-100 syringe.

Calculate this vial

01 · At a glance

Quickstart Highlights

GHRP-2 (pralmorelin) is a synthetic hexapeptide that potently stimulates growth hormone release by activating ghrelin receptors in the pituitary and hypothalamus [1] [2] . It has been used in clinical research as a diagnostic GH stimulant and in investigative treatment protocols for growth hormone deficiency [3] . This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements.

ReconstituteAdd 3.0 mL bacteriostatic water → ~ 3.33 mg/mL concentration.
Reference dose100–300 mcg once daily (gradual titration).
Easy measuringAt ~3.33 mg/mL, 1 unit ~ 33.3 mcg ; 100 mcg ~ 3 units and 300 mcg ~ 9 units on a U-100 syringe.
StorageLyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; avoid freeze–thaw cycles.
Start with sterile preparation, storage, and injection-site basics before using any calculator output. TNHL is a tracking and education tool only.

02 · Dosing & reconstitution

Dosing & Reconstitution Guide

A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

Phase / setup Dose & frequency Volume / units
Weeks 1–2100 mcg (0.1 mg)3 units (0.03 mL)
Weeks 3–4150 mcg (0.15 mg)4.5 units (0.045 mL)
Weeks 5–8200 mcg (0.2 mg)6 units (0.06 mL)
Weeks 9–12(optional) 250–300 mcg (0.25–0.3 mg) 7.5–9 units (0.075–0.09 mL)

100–300 mcg once daily (gradual titration).

Advanced / Aggressive Approach

Phase / setup Dose & frequency Volume / units
Weeks 1–2) 100 mcg (0.1 mg) 2× daily3 units (0.03 mL)
Weeks 3–4) 150 mcg (0.15 mg) 2× daily4.5 units (0.045 mL)
Weeks 5–8) 200 mcg (0.2 mg) 2–3× daily6 units (0.06 mL)

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall; avoid foaming.
  3. Gently swirl/roll until dissolved (do not shake).
  4. Label and refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.

03 · What you'll need

Supplies Needed

Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.

Peptide vial 10 mg
  • Match the label on the vial before calculating.
Diluent 3.0 mL
  • Use only the diluent appropriate for the compound and instructions.
Syringes U-100 or custom
  • Calculator output can be translated to syringe units.
Tracking Protocol Pal
  • Log dose dates, inventory, sites, and observations.

Protocol Overview

  • Goal: Stimulate pulsatile growth hormone release and elevate IGF‑1 levels over time [5] .
  • Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
  • Dose Range: 100–300 mcg daily with gradual titration.
  • Reconstitution: 3.0 mL per 10 mg vial (~3.33 mg/mL) for accurate unit measurements.
  • Storage: Lyophilized frozen; reconstituted refrigerated; use within ~4 weeks after reconstitution [8] .

Dosing Protocol

  • 100–300 mcg once daily (gradual titration).
  • Inject once daily subcutaneously, typically before sleep to coincide with natural GH pulsatility [4] . For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.
  • Total daily doses in the 600–900 mcg range (split across injections) have been studied but may accelerate GH response attenuation [4] . A 5‑days‑on/2‑days‑off cycling pattern may help maintain receptor sensitivity [7] .
  • If values change, rerun the calculator and update the protocol so future logs match the active plan.

Storage Instructions

  • Lyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; avoid freeze–thaw cycles.
  • Storage: Lyophilized frozen; reconstituted refrigerated; use within ~4 weeks after reconstitution [8] .
  • Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.

04 · Good to know

Important Notes

  • This GHRP-2 page is for educational research organization only.
  • Confirm route, dose, contraindications, monitoring, storage, and cycle decisions with qualified professional guidance.
  • Use sterile technique, rotate sites when applicable, and log missed doses, reactions, and inventory changes.

05 · How it works

How This Works

GHRP-2 (pralmorelin) is a synthetic hexapeptide that potently stimulates growth hormone release by activating ghrelin receptors in the pituitary and hypothalamus [1] [2] .

It has been used in clinical research as a diagnostic GH stimulant and in investigative treatment protocols for growth hormone deficiency [3] .

This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements.

The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.

06 · Daily habits

Lifestyle Factors

  • Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
  • Track body metrics only if they are relevant to the user's goal and approved data sources.
  • Use consistent timing and logging habits so adherence data is meaningful.

07 · What to expect

Potential Benefits & Side Effects

  • GHRP-2 observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
  • This section is not a claim of therapeutic benefit.

08 · Technique

Injection Technique

Pre-injection preparation
  • Wash hands with soap and water.
  • Wipe the vial stopper and chosen site with alcohol, then let both dry.
  • Confirm the vial concentration, calculator result, and intended draw amount before loading the syringe.
Injection procedure
  • Use the route and needle technique directed by a qualified professional or product instructions.
  • For subcutaneous injections, rotate sites and inject slowly to limit leakage and irritation.
  • Do not reuse needles or syringes.
Post-injection care
  • Dispose of sharps in a puncture-resistant container.
  • Return stored items promptly to the correct temperature.
  • Log dose, site, date, time, inventory change, and any observation.

09 · Evidence

References

TNHL options

Peptide collections stay passive.

Open the TNHL Stan Store option that fits the order size. Product details, checkout, and fulfillment stay off-site.

Related pages

Keep researching